Evidence map›Paper›PMID 25968604›Full record

ArticleEuropean journal of pediatrics2015

Segregation of S292F TPO gene mutation in three large Tunisian families with thyroid dyshormonogenesis: evidence of a founder effect.

Noura Bougacha-Elleuch, Nadia Charfi, Nabil Miled, Houda Bouhajja, Neila Belguith, Mouna Mnif, Paula Jaurge, Nessrine Chikhrouhou, Hammadi Ayadi, Mongia Hachicha and 1 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Long-Term Outcome of Patients with TPO Mutations.Journal of clinical medicine · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Noura Bougacha-ElleuchUnité Cibles pour le Diagnostic et la Thérapie, Centre de Biotechnologie Sfax, BP 1177, 3018, Sfax, Tunisia. noura.bougacha@gmail.com.
Nadia CharfiService d'Endocrinologie, CHU Hédi Chaker, Sfax, Tunisia.
Nabil MiledLaboratoire de Biochimie et de Génie Enzymatique des Lipases, Ecole Nationale d'Ingénieurs de Sfax, Route Soukra BP W, Sfax, Tunisia.
Houda BouhajjaUnité Cibles pour le Diagnostic et la Thérapie, Centre de Biotechnologie Sfax, BP 1177, 3018, Sfax, Tunisia.
Neila BelguithLaboratoire de Génétique Moléculaire Humaine, Faculté de Médecine, Sfax, Tunisia.
Mouna MnifService d'Endocrinologie, CHU Hédi Chaker, Sfax, Tunisia.
Paula JaurgeUnidade de Genética Molecular, Centro de Genética Médica Doutor Jacinto Magalhães, Centro Hospitalar do Porto, Porto, Portugal.
Nessrine ChikhrouhouService d'Endocrinologie, CHU Hédi Chaker, Sfax, Tunisia.
Hammadi AyadiUnité Cibles pour le Diagnostic et la Thérapie, Centre de Biotechnologie Sfax, BP 1177, 3018, Sfax, Tunisia.
Mongia HachichaService de Pédiatrie, CHU Hédi Chaker, Sfax, Tunisia.
Mohamed AbidService d'Endocrinologie, CHU Hédi Chaker, Sfax, Tunisia.
Hopital Universitaire Hedi Chaker · TNCentre of Biotechnology of Sfax · TNCentro Hospitalar do Porto · PTUniversity of Sfax · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledWe aimed to identify causal mutation(s) in 13 patients with thyroid dyshormonogenesis (TD) from three consanguineous Tunisian families. A 12-year clinical follow-up showed phenotypic variability ranging from the presence to the absence of goiter, sensorineural deafness, and mental retardation. Genetic analysis using microsatellite markers within two candidate genes (TPO and PDS) gave evidence of linkage with the TPO gene. Sequencing of its 17 exons and their flanking intron-exon junctions revealed the previously described c.875C>T (p.S292F) mutation in homozygous state. No additional mutations were found in either a 900 bp of the TPO gene promoter or PDS gene. In silico analysis showed that p.S292F mutation might reduce the catalytic cavity of the TPO which would restrict access of a potential substrate to the catalytic pocket. Using 4SNPs and one microsatellite marker in the TPO gene, an associated haplotype: G-C-G-G-214 was found, giving evidence of a founder mutation.

conclusionThis is the first description of a TD causing mutation in Tunisia and thus may help to develop a genetic screening protocol for congenital hypothyroidism in the studied region. Although structural modeling suggested a pathogenic effect of this mutation, functional studies are needed. Additional causing and/or modifier genes, together with late diagnosis could explain the clinical variability observed in our patients.

Indexed as

Founder EffectMutationAdolescentAdultAutoantigensChildCongenital HypothyroidismConsanguinityFemaleGenotypeHumansIodide PeroxidaseIron-Binding ProteinsMaleMembrane Transport ProteinsMiddle AgedAutoantigensIodide PeroxidaseIron-Binding ProteinsMembrane Transport ProteinsSLC26A4 protein, humanSulfate TransportersTPO protein, humanFounder effectMutationStructural modelingThyroid dyshormonogenesisTPO

Identifiers

PMID25968604
OpenAlexW787795336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.